Literature DB >> 29097431

A simple algorithm for the identification of clinical COPD phenotypes.

Pierre-Régis Burgel1,2, Jean-Louis Paillasseur3, Wim Janssens4, Jacques Piquet5, Gerben Ter Riet6, Judith Garcia-Aymerich7, Borja Cosio8, Per Bakke9, Milo A Puhan10, Arnulf Langhammer11, Inmaculada Alfageme12, Pere Almagro13, Julio Ancochea14, Bartolome R Celli15, Ciro Casanova16, Juan P de-Torres17, Marc Decramer4, Andrés Echazarreta18, Cristobal Esteban19, Rosa Mar Gomez Punter20, MeiLan K Han21, Ane Johannessen22, Bernhard Kaiser23, Bernd Lamprecht24, Peter Lange25, Linda Leivseth26, Jose M Marin27, Francis Martin28, Pablo Martinez-Camblor29,30, Marc Miravitlles31, Toru Oga32, Ana Sofia Ramírez33, Don D Sin34, Patricia Sobradillo35, Juan J Soler-Cataluña36, Alice M Turner37, Francisco Javier Verdu Rivera38, Joan B Soriano39, Nicolas Roche40,2.   

Abstract

This study aimed to identify simple rules for allocating chronic obstructive pulmonary disease (COPD) patients to clinical phenotypes identified by cluster analyses.Data from 2409 COPD patients of French/Belgian COPD cohorts were analysed using cluster analysis resulting in the identification of subgroups, for which clinical relevance was determined by comparing 3-year all-cause mortality. Classification and regression trees (CARTs) were used to develop an algorithm for allocating patients to these subgroups. This algorithm was tested in 3651 patients from the COPD Cohorts Collaborative International Assessment (3CIA) initiative.Cluster analysis identified five subgroups of COPD patients with different clinical characteristics (especially regarding severity of respiratory disease and the presence of cardiovascular comorbidities and diabetes). The CART-based algorithm indicated that the variables relevant for patient grouping differed markedly between patients with isolated respiratory disease (FEV1, dyspnoea grade) and those with multi-morbidity (dyspnoea grade, age, FEV1 and body mass index). Application of this algorithm to the 3CIA cohorts confirmed that it identified subgroups of patients with different clinical characteristics, mortality rates (median, from 4% to 27%) and age at death (median, from 68 to 76 years).A simple algorithm, integrating respiratory characteristics and comorbidities, allowed the identification of clinically relevant COPD phenotypes.
Copyright ©ERS 2017.

Entities:  

Mesh:

Year:  2017        PMID: 29097431     DOI: 10.1183/13993003.01034-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  20 in total

1.  Symptom Subtypes of Obstructive Sleep Apnea Predict Incidence of Cardiovascular Outcomes.

Authors:  Diego R Mazzotti; Brendan T Keenan; Diane C Lim; Daniel J Gottlieb; Jinyoung Kim; Allan I Pack
Journal:  Am J Respir Crit Care Med       Date:  2019-08-15       Impact factor: 21.405

Review 2.  Machine Learning Characterization of COPD Subtypes: Insights From the COPDGene Study.

Authors:  Peter J Castaldi; Adel Boueiz; Jeong Yun; Raul San Jose Estepar; James C Ross; George Washko; Michael H Cho; Craig P Hersh; Gregory L Kinney; Kendra A Young; Elizabeth A Regan; David A Lynch; Gerald J Criner; Jennifer G Dy; Stephen I Rennard; Richard Casaburi; Barry J Make; James Crapo; Edwin K Silverman; John E Hokanson
Journal:  Chest       Date:  2019-12-28       Impact factor: 9.410

3.  Early Endotyping: A Chance for Intervention in Chronic Obstructive Pulmonary Disease.

Authors:  Hans Petersen; Rodrigo Vazquez Guillamet; Paula Meek; Akshay Sood; Yohannes Tesfaigzi
Journal:  Am J Respir Cell Mol Biol       Date:  2018-07       Impact factor: 6.914

4.  "High-Risk" Clinical and Inflammatory Clusters in COPD of Chinese Descent.

Authors:  Pei Yee Tiew; Fanny Wai San Ko; Jayanth Kumar Narayana; Mau Ern Poh; Huiying Xu; Han Yee Neo; Li-Cher Loh; Choo Khoon Ong; Micheál Mac Aogáin; Jessica Han Ying Tan; Nabilah Husna Kamaruddin; Gerald Jiong Hui Sim; Therese S Lapperre; Mariko Siyue Koh; David Shu Cheong Hui; John Arputhan Abisheganaden; Augustine Tee; Krasimira Tsaneva-Atanasova; Sanjay H Chotirmall
Journal:  Chest       Date:  2020-02-22       Impact factor: 9.410

5.  Identifying clinically important COPD sub-types using data-driven approaches in primary care population based electronic health records.

Authors:  Maria Pikoula; Jennifer Kathleen Quint; Francis Nissen; Harry Hemingway; Liam Smeeth; Spiros Denaxas
Journal:  BMC Med Inform Decis Mak       Date:  2019-04-18       Impact factor: 2.796

6.  Reply to Polverino: Deconvoluting Chronic Obstructive Pulmonary Disease: Are B Cells the Frontrunners?

Authors:  Maha Zohra Ladjemi; Pierre Régis Burgel; Charles Pilette
Journal:  Am J Respir Crit Care Med       Date:  2019-05-01       Impact factor: 21.405

7.  The COPD multi-dimensional phenotype: A new classification from the STORICO Italian observational study.

Authors:  Raffaele Antonelli Incalzi; Giorgio Walter Canonica; Nicola Scichilone; Sara Rizzoli; Lucia Simoni; Francesco Blasi
Journal:  PLoS One       Date:  2019-09-13       Impact factor: 3.240

8.  Validation of a method to assess emphysema severity by spirometry in the COPDGene study.

Authors:  Mariaelena Occhipinti; Matteo Paoletti; James D Crapo; Barry J Make; David A Lynch; Vito Brusasco; Federico Lavorini; Edwin K Silverman; Elizabeth A Regan; Massimo Pistolesi
Journal:  Respir Res       Date:  2020-05-01

9.  Identifying Behavioral Phenotypes in Chronic Illness: Self-Management of COPD and Comorbid Hypertension.

Authors:  Grace M Perez-Benzo; Kimberly Muellers; Shiqi Chen; Bian Liu; Emilia Bagiella; Rachel O'Conor; Michael S Wolf; Juan P Wisnivesky; Alex D Federman
Journal:  Patient Educ Couns       Date:  2020-08-29

Review 10.  Artificial Intelligence and Machine Learning in Chronic Airway Diseases: Focus on Asthma and Chronic Obstructive Pulmonary Disease.

Authors:  Yinhe Feng; Yubin Wang; Chunfang Zeng; Hui Mao
Journal:  Int J Med Sci       Date:  2021-06-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.